Prof. Dr. Ulrich Walter

Other Original Publications (2001 - 2005)
1. Fischer, T.A., Palmetshofer, A., Gambaryan, S., Butt, E., Jassoy, C., Walter, U.,
Sopper, S. and Lohmann, S.M. (2001) Activation of cGMP-dependent protein kinase
Ibeta inhibits interleukin 2 release and proliferation of T cell receptor-stimulated
human peripheral T cells. J Biol Chem, 276, 5967-5974.
2. Maier, S., Lange, V., Simm, A., Walter, U. and Kirstein, M. (2001) Insulin fails to
modulate the cardiac L-type Ca2+ current in Type II diabetes patients--a possible link
to cardiac dysfunction in diabetes mellitus. Diabetologia, 44, 269.
3. Marienfeld, U., Walter, U. and Simm, A. (2001) Inhibition of rat cardiac fibroblast
growth by cAMP--but not by cGMP- dependent protein kinase. Basic Res Cardiol,
96, 184-191.
4. Mulsch, A., Oelze, M., Kloss, S., Mollnau, H., Topfer, A., Smolenski, A., Walter, U.,
Stasch, J.P., Warnholtz, A., Hink, U., Meinertz, T. and Munzel, T. (2001) Effects of in
vivo nitroglycerin treatment on activity and expression of the guanylyl cyclase and
cGMP-dependent protein kinase and their downstream target vasodilator-stimulated
phosphoprotein in aorta. Circulation, 103, 2188-2194.
5. Bader, B., Butt, E., Palmetshofer, A., Walter, U., Jarchau, T. and Drueckes, P. (2001)
A cGMP-dependent protein kinase assay for high throughput screening based on
time-resolved fluorescence resonance energy transfer. J Biomol Screen, 6, 255-264.
6. Gambaryan, S., Hauser, W., Kobsar, A., Glazova, M. and Walter, U. (2001)
Distribution, cellular localization, and postnatal development of VASP and Mena
expression in mouse tissues. Histochem Cell Biol, 116, 535-543.
7. Grossmann, R., Geisen, U. and Walter, U. (2001) In vivo haemostatic effects of
activated prothrombin complex concentrate and recombinant factor VIIa in a
haemophilia A patient with inhibitors. Haemophilia, 7, 589-591.
8. Zimmermann, J., Labudde, D., Jarchau, T., Walter, U., Oschkinat, H. and Ball, L.J.
(2002) Relaxation, equilibrium oligomerization, and molecular symmetry of the VASP
(336-380) EVH2 tetramer. Biochemistry, 41, 11143-11151.
9. Zabel, U., Kleinschnitz, C., Oh, P., Nedvetsky, P., Smolenski, A., Muller, H., Kronich,
P., Kugler, P., Walter, U., Schnitzer, J.E. and Schmidt, H.H. (2002) Calciumdependent
membrane association sensitizes soluble guanylyl cyclase to nitric oxide.
Nat Cell Biol, 4, 307-311.
10. Warnholtz, A., Mollnau, H., Heitzer, T., Kontush, A., Moller-Bertram, T., Lavall, D.,
Giaid, A., Beisiegel, U., Marklund, S.L., Walter, U., Meinertz, T. and Munzel, T.
(2002) Adverse effects of nitroglycerin treatment on endothelial function, vascular
nitrotyrosine levels and cGMP-dependent protein kinase activity in hyperlipidemic
Watanabe rabbits. J Am Coll Cardiol, 40, 1356-1363.
11. Schulz, E., Tsilimingas, N., Rinze, R., Reiter, B., Wendt, M., Oelze, M., Woelken-
Weckmuller, S., Walter, U., Reichenspurner, H., Meinertz, T. and Munzel, T. (2002)
Functional and biochemical analysis of endothelial (dys)function and NO/cGMP
signaling in human blood vessels with and without nitroglycerin pretreatment.
Circulation, 105, 1170-1175.
12. Renne, T., Sugiyama, A., Gailani, D., Jahnen-Dechent, W., Walter, U. and Muller-
Esterl, W. (2002) Fine mapping of the H-kininogen binding site in plasma prekallikrein
apple domain 2. Int Immunopharmacol, 2, 1867-1873.
13. Mollnau, H., Wendt, M., Szocs, K., Lassegue, B., Schulz, E., Oelze, M., Li, H.,
Bodenschatz, M., August, M., Kleschyov, A.L., Tsilimingas, N., Walter, U.,
Forstermann, U., Meinertz, T., Griendling, K. and Munzel, T. (2002) Effects of
angiotensin II infusion on the expression and function of NAD(P)H oxidase and
components of nitric oxide/cGMP signaling. Circ Res, 90, E58-65.
14. Aktas, B., Honig-Liedl, P., Walter, U. and Geiger, J. (2002) Inhibition of platelet
P2Y12 and alpha2A receptor signaling by cGMP- dependent protein kinase.
Biochem Pharmacol, 64, 433-439.
3